Product Code: ETC6186015 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for NTD treatment in Australia overlaps with public health and humanitarian sectors, particularly through medical supply donations, clinical research, and partnerships with global organizations. Pharmaceutical companies and NGOs in Australia contribute to the development and distribution of therapies targeting diseases like leishmaniasis, Chagas disease, and schistosomiasis.
The treatment landscape overlaps with global pharmaceutical efforts and humanitarian programs. Australian institutions are collaborating with international health organizations to facilitate the development and distribution of essential drugs. Interest in repurposing existing medications is also contributing to advancements in this segment.
Barriers to market development include high costs associated with importing medications not manufactured locally, inconsistent inclusion in national health priority lists, and fragmented efforts in drug donation and distribution programs for international aid.
Redundantly listed but crucial, the NTD treatment sector also benefits from Australia`s health diplomacy and R&D efforts. Investors have the chance to engage in formulation development, orphan drug commercialization, and deployment logistics in international health aid frameworks.
Similar to diagnosis and general NTD strategies, the government offers funding through global health grants and participates in WHO-coordinated drug donation programs. Although domestic demand is minimal, policy alignment with international health goals ensures ongoing research, clinical trials, and therapeutic innovation in the treatment of NTDs.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neglected Tropical Diseases Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neglected Tropical Diseases Treatment Market - Industry Life Cycle |
3.4 Australia Neglected Tropical Diseases Treatment Market - Porter's Five Forces |
3.5 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Australia Neglected Tropical Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Neglected Tropical Diseases Treatment Market Trends |
6 Australia Neglected Tropical Diseases Treatment Market, By Types |
6.1 Australia Neglected Tropical Diseases Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Mediterranean Fever, 2021- 2031F |
6.1.4 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Ebola Virus Infection, 2021- 2031F |
6.1.5 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Chagas Disease, 2021- 2031F |
6.1.6 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Zika Virus Infection, 2021- 2031F |
6.1.7 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Chikungunya, 2021- 2031F |
6.1.8 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Neglected Tropical Diseases Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.3 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.3 Australia Neglected Tropical Diseases Treatment Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4 Australia Neglected Tropical Diseases Treatment Market, By End use |
6.4.1 Overview and Analysis |
6.4.2 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Clinical Labs, 2021- 2031F |
6.4.3 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Hospitals /Clinics, 2021- 2031F |
6.4.4 Australia Neglected Tropical Diseases Treatment Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 Australia Neglected Tropical Diseases Treatment Market Import-Export Trade Statistics |
7.1 Australia Neglected Tropical Diseases Treatment Market Export to Major Countries |
7.2 Australia Neglected Tropical Diseases Treatment Market Imports from Major Countries |
8 Australia Neglected Tropical Diseases Treatment Market Key Performance Indicators |
9 Australia Neglected Tropical Diseases Treatment Market - Opportunity Assessment |
9.1 Australia Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Australia Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Australia Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Australia Neglected Tropical Diseases Treatment Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Australia Neglected Tropical Diseases Treatment Market - Competitive Landscape |
10.1 Australia Neglected Tropical Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Neglected Tropical Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |